Literature DB >> 19194694

Self administration of heroin and cocaine in morphine-dependent and morphine-withdrawn rhesus monkeys.

Lisa R Gerak1, Ruggero Galici, Charles P France.   

Abstract

RATIONALE: Dependence can develop during chronic opioid use, and the emergence of withdrawal might promote drug taking.
OBJECTIVE: This study examined how chronic morphine administration or withdrawal modified self administration of heroin or cocaine.
METHODS: Four monkeys responded under a fixed ratio 10 schedule to receive i.v. infusions of heroin (0.56-560 microg/kg/infusion) or cocaine (1-100 microg/kg/infusion). Monkeys received morphine twice daily; the final dose was 10 mg/kg/12 h. Dose-effect curves for heroin or cocaine were determined in 150-min sessions throughout morphine administration and during temporary suspension when withdrawal signs were also monitored. Heroin dose-effect curves and withdrawal signs were determined daily following termination of morphine administration.
RESULTS: Before monkeys received morphine, heroin, and cocaine maintained responding with unit doses of 1.78 microg/kg of heroin and 10 microg/kg/injection of cocaine resulting in, on average, 13.4 and 20.8 infusions, respectively. When monkeys received morphine daily, self administration of heroin and cocaine decreased to, on average, 3.1 and 11.3 infusions, respectively. Responding for heroin or cocaine recovered following temporary (17-53 h) suspension of morphine administration. The number of heroin infusions and total withdrawal signs increased when morphine administration was terminated. Withdrawal signs peaked 3-4 days after morphine; however, the number of infusions remained elevated for 8 weeks.
CONCLUSIONS: Changes in self administration responding did not precisely covary with signs of withdrawal and responding for small doses of heroin persisted long after discontinuation of morphine, suggesting that non-pharmacologic (e.g., conditioned reinforcing) effects might contribute to the maintenance of lever pressing under these conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194694      PMCID: PMC3460695          DOI: 10.1007/s00213-009-1471-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.

Authors:  Tracy Beswick; David Best; Sian Rees; Jenny Bearn; Michael Gossop; John Strang
Journal:  Addict Biol       Date:  2003-03       Impact factor: 4.280

2.  Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.

Authors:  Michael Gossop; Duncan Stewart; Nadine Browne; John Marsden
Journal:  Addiction       Date:  2002-10       Impact factor: 6.526

3.  Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys.

Authors:  L R Gerak; C P France
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

4.  Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.

Authors:  Douglas Longshore; Jeffrey Annon; M Douglas Anglin; Richard A Rawson
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

5.  Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone.

Authors:  M R Carrera; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

6.  The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.

Authors:  G Winger; J H Woods
Journal:  Drug Alcohol Depend       Date:  2001-05-01       Impact factor: 4.492

7.  Cocaine and other indirect-acting monoamine agonists differentially attenuate a naltrexone discriminative stimulus in morphine-treated rhesus monkeys.

Authors:  Lance R McMahon; Stacy L Sell; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2003-10-20       Impact factor: 4.030

8.  Chronic opiate treatment enhances both cocaine-reinforced and cocaine-seeking behaviors following opiate withdrawal.

Authors:  Shaunteng He; Kenneth Grasing
Journal:  Drug Alcohol Depend       Date:  2004-08-16       Impact factor: 4.492

9.  Chronic opioid exposure produces increased heroin self-administration in rats.

Authors:  John R Walker; Scott A Chen; Heather Moffitt; Charles E Inturrisi; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2003-05       Impact factor: 3.533

10.  Low dose of heroin inhibits drug-seeking elicited by cues after prolonged withdrawal from heroin self-administration in rats.

Authors:  Wenhua Zhou; Fuqiang Zhang; Shuaien Tang; Huifen Liu; Miaojun Lai; Guodong Yang
Journal:  Neuroreport       Date:  2004-03-22       Impact factor: 1.837

View more
  13 in total

1.  Models of neurological disease (substance abuse): self-administration in monkeys.

Authors:  Donna M Platt; Galen Carey; Roger D Spealman
Journal:  Curr Protoc Pharmacol       Date:  2011-12

2.  Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.

Authors:  David R Maguire; Charles P France
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

3.  Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats.

Authors:  Ziva D Cooper; Yong-Gong Shi; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2010-08-05       Impact factor: 4.530

4.  OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention.

Authors:  David R Maguire; Lisa R Gerak; Gerta Cami-Kobeci; Stephen M Husbands; Charles P France; Barbara Belli; Peter Flynn
Journal:  J Pharmacol Exp Ther       Date:  2019-11-20       Impact factor: 4.030

5.  Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal.

Authors:  Katharine M Seip; Brian Reed; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2011-07-07       Impact factor: 4.530

Review 6.  Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  Jennifer L Whistler
Journal:  Drug Alcohol Depend       Date:  2012-01-09       Impact factor: 4.492

7.  Effects of daily morphine administration and deprivation on choice and demand for remifentanil and cocaine in rhesus monkeys.

Authors:  Tammy Wade-Galuska; Chad M Galuska; Gail Winger
Journal:  J Exp Anal Behav       Date:  2011-01       Impact factor: 2.468

8.  Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys.

Authors:  Peter F Weed; Charles P France; Lisa R Gerak
Journal:  J Pharmacol Exp Ther       Date:  2017-04-24       Impact factor: 4.030

9.  Effects of acute and chronic morphine on delay discounting in pigeons.

Authors:  Amy K Eppolito; Charles P France; Lisa R Gerak
Journal:  J Exp Anal Behav       Date:  2013-04-02       Impact factor: 2.468

10.  Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: A behavioral economic analysis.

Authors:  Rebecca S Hofford; Joshua S Beckmann; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2016-08-03       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.